SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·07/30/2025 12:08:36
Listen to the news
Gainers
- Replimune Group (NASDAQ:REPL) stock moved upwards by 73.3% to $6.5 during Wednesday's pre-market session. The company's market cap stands at $291.7 million.
- Capricor Therapeutics (NASDAQ:CAPR) shares moved upwards by 20.47% to $8.12. The company's market cap stands at $308.0 million.
- Sarepta Therapeutics (NASDAQ:SRPT) shares moved upwards by 13.71% to $18.0. The company's market cap stands at $1.5 billion.
- Penumbra (NYSE:PEN) stock moved upwards by 13.58% to $258.0. The company's market cap stands at $8.7 billion. The company's, Q2 earnings came out yesterday.
- Cellectar Biosciences (NASDAQ:CLRB) stock increased by 11.41% to $5.25. The market value of their outstanding shares is at $13.4 million.
- Protagenic Therapeutics (NASDAQ:PTIX) stock increased by 10.74% to $3.4. The market value of their outstanding shares is at $2.6 million.
Losers
- VYNE Therapeutics (NASDAQ:VYNE) stock fell 54.0% to $0.66 during Wednesday's pre-market session. The market value of their outstanding shares is at $23.9 million.
- Healthcare Triangle (NASDAQ:HCTI) shares decreased by 39.38% to $0.03. The company's market cap stands at $20.7 million.
- Mural Oncology (NASDAQ:MURA) stock declined by 21.85% to $1.86. The market value of their outstanding shares is at $41.0 million.
- Cardiff Oncology (NASDAQ:CRDF) shares decreased by 21.16% to $2.61. The market value of their outstanding shares is at $220.2 million. The company's, Q2 earnings came out yesterday.
- TNF Pharmaceuticals (NASDAQ:TNFA) stock declined by 14.32% to $0.13. The company's market cap stands at $2.1 million.
- NeOnc Technologies (NASDAQ:NTHI) shares declined by 11.63% to $4.41. The market value of their outstanding shares is at $94.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.